. Author manuscript; available in PMC: 2010 Jun 18.

Published in final edited form as: Pediatr Allergy Immunol. 2009 Aug 27;21(1 Pt 1):82–89. doi: 10.1111/j.1399-3038.2009.00926.x

Table 2.

Relationship between Infant Weight Gain Group and Features of Asthma Impairment and Risk Domains at Ages 5–6 Years

Variable	Decelerated N=26	Weight Gain Category Average N=83	Accelerated N=88	P
FEV_0.5 – mean % predicted (95% CI)	92 (84–100)	89 (84–94)	94 (90–98)	.26
FEV_0.5/FVC – mean % (95% CI)	69.7 (65.0–74.3)	67.5 (65.0–70.0)	66.3 (64.1–68.6)	.41
Episode Free Days – mean no of days/yr (95% CI)^*	330 (303–346)	321 (305–334)	316 (299–329)	.57
Days Using Controller Medication – mean no days/yr (95% CI) ^†	19.6 (−23.4–62.6)	49.0 (25.6–72.5)	44.3 (21.6–66.9)	.45
Exacerbations requiring a course of systemic corticosteroid – no./100 child-yr (95% CI)^*	59.8 (44.7–80.1)	89.8 (78.0–103.5)	91.1 (79.6–104.4)	.01
Unscheduled physician visits – no./100 child-yr (95% CI)^*	53.1 (38.8–72.8)	98.3 (85.8–112.6)	108.8 (95.9–123.4)	<.001

data from all three study years, but adjusted for treatment group

^†

observation year only